The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero
Anthera Pharmaceuticals Inc (ANTH)

Anthera Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines that benefit patients with medical needs. Co. has two product candidates, Sollpura and blisibimod. Sollpura™ is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients with Exocrine Pancreatic Insufficiency, often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, systemic lupus erythematosus, lupus nephritis, and others.

Company Name:  Anthera Pharmaceuticals Inc
Website:  www.anthera.com
Sector:  Biotechnology
Number of ETFs Holding ANTH:  1
Total Market Value Held by ETFs:  $2063
Total Market Capitalization:  $15.00M
% of Market Cap. Held by ETFs:  0.01%
September 22, 2017    11:35 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes



Buy (2.67 out of 4)
26th percentile
(ranked lower than approx. 74% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Anthera Pharmaceuticals Inc (ANTH) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2017, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.